(Q40010912)

16 September 2017

title

Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells (English)

1 reference

16 September 2017

A Hiasa

1

1 reference

16 September 2017

M Hirayama

2

1 reference

16 September 2017

H Nishikawa

3

1 reference

16 September 2017

S Kitano

4

1 reference

16 September 2017

I Nukaya

5

1 reference

16 September 2017

S S Yu

6

1 reference

16 September 2017

J Mineno

7

1 reference

16 September 2017

I Kato

8

1 reference

16 September 2017

H Shiku

9

1 reference

16 September 2017

publication date

21 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

15

1 reference

16 September 2017

issue

9

1 reference

16 September 2017

page(s)

695-699

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303099

16 September 2017

exact match

0 references

cites work

NY-ESO-1: review of an immunogenic tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Human T cell responses against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

A new family of mouse genes homologous to the human MAGE genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303099

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3303099

1 reference

Dimensions Publication ID

16 September 2017

1041119412

0 references

1 reference